Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial

2021 ◽  
pp. 1-9
Author(s):  
Yongliang Feng ◽  
Tian Yao ◽  
Yujie Han ◽  
Jing Shi ◽  
Shuang Dong ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Hepatitis B ◽  
Controlled Trial ◽  
Hepatitis B Vaccine ◽  
High Dose

scholarly journals Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients

2016 ◽  
Vol 12 (9) ◽  
pp. 2317-2321
Author(s):  
Alba Vilajeliu ◽  
Víctor-Guillermo Sequera ◽  
Alberto L. García-Basteiro ◽  
Elisa Sicuri ◽  
Marta Aldea ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Hepatitis B ◽  
Hepatitis B Vaccine

scholarly journals Immunogenicity and safety of high-dose hepatitis B vaccine among drug users: A randomized, open-labeled, blank-controlled trial

2017 ◽  
Vol 13 (6) ◽  
pp. 1297-1303 ◽  
Author(s):  
Yongliang Feng ◽  
Jing Shi ◽  
Linying Gao ◽  
Tian Yao ◽  
Dan Feng ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Drug Users ◽  
Controlled Trial ◽  
Hepatitis B Vaccine ◽  
High Dose
Sign in / Sign up

Export Citation Format

Share Document